Live
10x Genomics NewsThe 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo FinanceBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-May 15, 2026BioPharma DiveFDA approves AstraZeneca’s new kind of hypertension drugBioPharma DiveMerck ADC, licensed from China, hits mark in first big global trialBoston ScientificBoston Scientific buys $1.5B stake in TAVR developer MiRus - MedTech DiveEndpoints NewsRegeneron reaches $125M Parabilis deal for hard-to-catch drug targetsFierceBiotechBioMarin’s $270M Inozyme bet looks in trouble after rare disease drug misses key ph. 3 goalFierceBiotechAfter rare disease flop, cash-strapped Quince finds salvation in reverse mergerBioWorldBiggest gainers and losers for May 11-15, 2026Endpoints NewsDesign Therapeutics' Friedreich's ataxia data; Vincentage's obesity results from ChinaQiagenQiagen stock (NL0012169213): QIAGEN’s U.S. diagnostics exposure stays in focus - AD HOC NEWS

Archive

Latest Oldest
Total 11419
Page 503 / 635
Query --